title: New Drugs 2016, part 3.
authors: Remington Professor of Pharmacy Philadelphia College of Pharmacy University of the Sciences Philadelphia, Pa.
authors: Daniel A
authors: DA
authors: Hussar
mesh_terms: D000249:Adenosine Monophosphate / Q000031:analogs & derivatives / Q000627:therapeutic use; D000631:Aminopyridines / Q000032:analysis / Q000494:pharmacology / Q000627:therapeutic use; D018927:Anti-Asthmatic Agents / Q000032:analysis / Q000494:pharmacology / Q000627:therapeutic use; D061067:Antibodies, Monoclonal, Humanized / Q000032:analysis / Q000494:pharmacology / Q000627:therapeutic use; D000925:Anticoagulants / Q000032:analysis / Q000494:pharmacology / Q000627:therapeutic use; D000932:Antiemetics / Q000032:analysis / Q000494:pharmacology / Q000627:therapeutic use; D052117:Benzodioxoles / Q000032:analysis / Q000494:pharmacology / Q000627:therapeutic use; D002756:Cholagogues and Choleretics / Q000032:analysis / Q000494:pharmacology / Q000627:therapeutic use; D019005:Cystic Fibrosis Transmembrane Conductance Regulator / Q000032:analysis / Q000494:pharmacology / Q000627:therapeutic use; D003840:Deoxycholic Acid / Q000032:analysis / Q000494:pharmacology / Q000627:therapeutic use; D003967:Diarrhea / Q000188:drug therapy; D017277:Drug Approval; D007093:Imidazoles / Q000032:analysis / Q000494:pharmacology / Q000627:therapeutic use; D043183:Irritable Bowel Syndrome / Q000503:physiopathology; D013141:Spiro Compounds
chemical_list: D000631:Aminopyridines; D018927:Anti-Asthmatic Agents; D061067:Antibodies, Monoclonal, Humanized; D000925:Anticoagulants; D000932:Antiemetics; D052117:Benzodioxoles; D002756:Cholagogues and Choleretics; D007093:Imidazoles; D013141:Spiro Compounds; D003840:Deoxycholic Acid; D019005:Cystic Fibrosis Transmembrane Conductance Regulator; D000249:Adenosine Monophosphate; C117446:cangrelor; C434107:mepolizumab; C569105:lumacaftor; C578834:rolapitant